col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


95 Results       Page 1

 [1] 
Elsevier: Microbial Pathogenesis
  original article Date Title Authors   All Authors
1 [GO] 2022―Oct―15 Nasopharyngeal microbiome of COVID-19 patients revealed a distinct bacterial profile in deceased and recovered individuals Dinesh Kumar, Ramesh Pandit, Sonal Sharma, Janvi Raval, Zarna Patel, Madhvi Joshi, Chaitanya G. Joshi
2 [GO] 2022―Oct―13 Novel coronavirus mutations: Vaccine development and challenges Wan-Rong Luo, Xiao-Min Wu, Wei Wang, Jun-Ling Yu, Qing-Qing Chen, Xue Zhou, et al. (+5)
3 [GO] 2022―Sep―30 Investigation of hemogram, oxidative stress, and some inflammatory marker levels in neonatal calves with escherichia coli and coronavirus diarrhea Omer Aydin, Nergis Ulas, Aydin Genc, Sümeyye Baysal, Ozge Kandemir, Mustafa Sinan Aktas
4 [GO] 2022―Sep―26 Downregulation of ACE, AGTR1, and ACE2 genes mediating SARS-CoV-2 pathogenesis by gut microbiota members and their postbiotics on Caco-2 cells Sara Ahmadi Badi, Amin Malek, Alessandro Paolini, Mahya Rouhollahi Masoumi, Seyed Amirhesam Seyedi, Amir Amanzadeh, et al. (+3)
5 [GO] 2022―Sep―19 The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial Mehrdad Mosadegh, Aref Khalkhali, Yousef Erfani, Manije Nezamdoost
6 [GO] 2022―Sep―15 Global distribution of ACE1 (rs4646994) and ACE2 (rs2285666) polymorphisms associated with COVID-19: A systematic review and meta-analysis Masoud Keikha, Mohsen Karbalaei
7 [GO] 2022―Sep―02 Efficacy of COVID-19 vaccines Mohamed J. Saadh, Saif Aldeen Jaber
8 [GO] 2022―Aug―24 Preparation and pre-clinical evaluation of flagellin-adjuvanted NOM vaccine candidate formulated with Spike protein against SARS-CoV-2 in mouse model Hossein Farshidi, Narges Farshidi, Tayebeh Ghaedi, Mehdi Hassaniazad, Ebrahim Eftekhar, Mohammad Reza Asadi Karam, et al. (+4)
9 [GO] 2022―Aug―23 Evaluating the ability of the NLHA2 and artificial neural network models to predict COVID-19 severity, and comparing them with the four existing scoring systems Yue Dong, Kai Wang, Xu Zou, Xiaoping Tan, Yi Zang, Xinyu Li, et al. (+6)
10 [GO] 2022―Aug―10 Discovery of natural products to block SARS-CoV-2 S-protein interaction with Neuropilin-1 receptor: A molecular dynamics simulation approach Eman Alshawaf, Maha M. Hammad, Sulaiman K. Marafie, Hamad Ali, Fahd Al-Mulla, Jehad Abubaker, Anwar Mohammad
11 [GO] 2022―Aug―07 Gut bacteria, bacteriophages, and probiotics: Tripartite mutualism to quench the SARS-CoV2 storm Tahereh Zeinali, Niloofar Faraji, Farahnaz Joukar, Mohammadali Khan Mirzaei, Hossnieh Kafshdar Jalali, Mohammad Shenagari, Fariborz Mansour-Ghanaei
12 [GO] 2022―Aug―06 Unique mutations in SARS-CoV-2 omicron subvariants' non-spike proteins: Potential impact on viral pathogenesis and host immune evasion Anamica Hossain, Shammi Akter Trishna, Alfi Anjum Rashid, Sabik Khair, A.S.M. Rubayet Ul Alam
13 [GO] 2022―Jul―31 Evaluating the immunogenicity of gold nanoparticles conjugated RBD with Freund's adjuvant as a potential vaccine against SARS-CoV-2 Mahtab Moshref Javadi, Mozhgan Taghdisi Hosseinzadeh, Neda Soliemani, Foad Rommasi
14 [GO] 2022―Jul―21 Moraxella occupied the largest proportion in the nasal microbiome in healthy children, which potential protect them from COVID-19 Xia Yu, Li Wang, XueMei Zheng, Yizhou Wen, Zhirong Zhang, Lingxia Fan, et al. (+4)
15 [GO] 2022―Jun―25 ABO blood group and link to COVID-19: A comprehensive review of the reported associations and their possible underlying mechanisms Eric Pereira, Stela Felipe, Raquel de Freitas, Valdevane Araújo, Paula Soares, Jannison Ribeiro, et al. (+6)
16 [GO] 2022―Jun―08 Repurposing of anti-lung cancer drugs as multi-target inhibitors of SARS-CoV-2 proteins: An insight from molecular docking and MD-simulation study Rahimasoom Reza, Tanmoy Dutta, Nabajyoti Baildya, Narendra Nath Ghosh, Abdul Ashik Khan, Rajesh Kumar Das
17 [GO] 2022―Jun―08 The influence of new SARS-CoV-2 variant Omicron (B.1.1.529) on vaccine efficacy, its correlation to Delta variants: A computational approach Prashant Ranjan, Chandra Devi, Kaaviyapriya Arulmozhi Devar, Parimal Das
18 [GO] 2022―Jun―08 Characterization of long COVID-19 manifestations and its associated factors: A prospective cohort study from Iran Mona Sadat Larijani, Fatemeh Ashrafian, Fahimeh Bagheri Amiri, Mohammad Banifazl, Anahita Bavand, Afsaneh Karami, et al. (+2)
19 [GO] 2022―May―30 Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system Madhura Punekar, Manas Kshirsagar, Chaitanya Tellapragada, Kanchankumar Patil
20 [GO] 2022―May―29 Comparison of pathogenicity of different subgenotype porcine reproductive and respiratory syndrome viruses isolated in China Jie Zhang, Juan Bai, Yangyang Sun, Xing Liu, Yanni Gao, Xianwei Wang, et al. (+2)
21 [GO] 2022―May―18 SARS-COV-2 RBD (Receptor binding domain) mutations and variants (A sectional-analytical study) Faezeh Hajazadeh, Sayyad Khanizadeh, Hamidreza Khodadadi, Yaser Mokhayeri, Mehdi Ajorloo, Asra Malekshahi, Ezatoallah Heydari
22 [GO] 2022―May―15 The association of decreased HLA-G+ immune cell frequencies with critical COVID-19 patients Somayeh Ramzannezhad, Mona Tarighi, Mousa Mohammadnia-Afrouzi, So�h Aghapour, Mojgan Bagherzadeh, Zahra Ahmadnia, et al. (+4)
23 [GO] 2022―Apr―22 Detection and molecular characteristics of canine coronavirus in Chengdu city, Southwest China from 2020 to 2021 Xue Sha, Yan Li, Jian Huang, Qun Zhou, Xin Song, Bin Zhang
24 [GO] 2022―Apr―09 Clinical impact of Candida respiratory tract colonization and acute lung infections in critically ill patients with COVID-19 pneumonia Mahzad Erami, Omid Raiesi, Mansooreh Momen-Heravi, Muhammad Ibrahim Getso, Mojtaba Fakhrehi, Narges Mehri, et al. (+4)
25 [GO] 2022―Apr―02 Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2 B. Uma Reddy, Nanda Kishore Routhu, Anuj Kumar
26 [GO] 2022―Mar―28 NGS analysis of nasopharyngeal microbiota in SARS-CoV-2 positive patients during the first year of the pandemic in the Campania Region of Italy Rosa Giugliano, Assunta Sellitto, Carlo Ferravante, Teresa Rocco, Ylenia D'Agostino, Elena Alexandrova, et al. (+9)
27 [GO] 2022―Mar―25 Accuracy of clustered regularly interspaced short palindromic repeats (CRISPR) to diagnose COVID-19, a meta-analysis Song Wang, Jiayi Hu, Chuanying Sui, Guangliang He, Zihan Qu, Xiaofei Chen, et al. (+3)
28 [GO] 2022―Mar―22 Structure-based screening of natural product libraries in search of potential antiviral drug-leads as first-line treatment to COVID-19 infection S.J. Aditya Rao, Nandini P. Shetty
29 [GO] 2022―Mar―12 Convalescent plasma therapy in patients with severe COVID-19, A single-arm, retrospective study Ladan Ghadami, Mehrdad Hasibi, Ali Asadollahi-Amin, Behzad asanjarani, Mohammad Farahmand, Hamed Abdollahi
30 [GO] 2022―Feb―10 Clinical and experimental bacteriophage studies: Recommendations for possible approaches for standing against SARS-CoV-2 Khashayar Shahin, Lili Zhang, Mohammad Hossein Mehraban, Jean-Marc Collard, Abolghasem Hedayatkhah, Mojtaba Mansoorianfar, et al. (+2)
31 [GO] 2022―Jan―26 The effect of IGF-1 plasma concentration on COVID-19 severity Ebrahim Hazrati, Mohammad Gholami, Ramin Hamidi Farahani, Khodayar Ghorban, Morteza Ghayomzadeh, Negin Hosseini Rouzbahani
32 [GO] 2022―Jan―19 Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India Pushpendra Singh, Kuldeep Sharma, Priyanka Singh, Anudita Bhargava, Sanjay Singh Negi, Pratibha Sharma, et al. (+4)
33 [GO] 2022―Jan―15 Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions Yasemin Genç Bahçe, Ömer Acer, Osman Özüdoğru
34 [GO] 2021―Nov―20 The role of polyspecific T-cell exhaustion in severe outcomes for COVID-19 patients having latent pathogen infections such as Toxoplasma gondii Kevin Roe
35 [GO] 2021―Nov―18 SARS-CoV-2 Re-infection rate in Iranian COVID-19 cases within one-year follow-up Mostafa Salehi-Vaziri, Mohammad Hassan Pouriayevali, Fatemeh Fotouhi, Tahmineh Jalali, Mohammad Banifazl, Behrokh Farahmand, et al. (+12)
36 [GO] 2021―Oct―13 SARS-CoV-2 mutational cascades and the risk of hyper-exponential growth John M. Halley, Despoina Vokou, Georgios Pappas, Ioannis Sainis
37 [GO] 2021―Oct―13 Investigating the conformational dynamics of SARS-CoV-2 NSP6 protein with emphasis on non-transmembrane 91-112 & 231-290 regions Amit Kumar, Prateek Kumar, Kumar Udit Saumya, Rajanish Giri
38 [GO] 2021―Sep―20 Human beta-defensins 2 and 4 are dysregulated in patients with coronavirus disease 19 Noor T. Al-Bayatee, Ali H. Ad'hiah
39 [GO] 2021―Sep―13 An evidence of microalgal peptides to target spike protein of COVID-19: In silico approach Davoodbasha MubarakAli, Jaulikar Mohamed Saalis, Raghunathan Sathya, Navabshan Irfan, Jung-Wan Kim
40 [GO] 2021―Aug―28 HantavirusesDB: Vaccinomics and RNA-based therapeutics database for the potentially emerging human respiratory pandemic agents Abbas Khan, Shahzeb Khan, Sajjad Ahmad, Zeeshan Anwar, Zahid Hussain, Muhammad Safdar, et al. (+7)
41 [GO] 2021―Jul―30 Host metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approach S.T.R. Moolamalla, Rami Balasubramanian, Ruchi Chauhan, U. Deva Priyakumar, P.K. Vinod
42 [GO] 2021―Jul―26 Rescue of recombinant canine distemper virus that expresses S1 subunit of SARS-CoV-2 spike protein in vitro Fuxiao Liu, Jiahui Lin, Qianqian Wang, Hu Shan
43 [GO] 2021―Jul―24 Interferon β, an enhancer of the innate immune response against SARS-CoV-2 infection Suresh Kumar Kali, Peter Dröge, Priyatharshini Murugan
44 [GO] 2021―Jul―21 Transcriptomic profiling reveals different innate immune responses in primary alveolar macrophages infected by two highly homologous porcine reproductive and respiratory syndrome viruses with distinct virulence Shubin Li, Xinshuai Li, Ming Qiu, Jixiang Li, Yanzhao Xiao, Hong Lin, et al. (+3)
45 [GO] 2021―Jun―24 Daytime variation in SARS-CoV-2 infection and cytokine production Aïssatou Bailo Diallo, Gay Laetitia, Coiffard Benjamin, Leone Marc, Mezouar Soraya, Mege Jean-Louis
46 [GO] 2021―Jun―19 Construction of an autophagy interaction network based on competitive endogenous RNA reveals the key pathways and central genes of SARS-CoV-2 infection in vivo Zhihao Chen, Xi Wang, Liubing Li, Mingxiao Han, Min Wang, Ziyuan Li, et al. (+4)
47 [GO] 2021―Jun―18 Potential biomarkers for the early prediction of SARS-COV-2 disease outcome Vignesh Mariappan, P.S. Manoharan, Pajanivel R, Lokesh Shanmugam, S.R. Rao, Agieshkumar Balakrishna Pillai
48 [GO] 2021―Jun―10 Conformational dynamics of 13 amino acids long NSP11 of SARS-CoV-2 under membrane mimetics and different solvent conditions Kundlik Gadhave, Prateek Kumar, Ankur Kumar, Taniya Bhardwaj, Neha Garg, Rajanish Giri
49 [GO] 2021―Jun―04 Immune mediating molecules and pathogenesis of COVID-19-associated neurological disease HariOm Singh, Amita Singh, Abdul Arif Khan, Vivek Gupta
50 [GO] 2021―Jun―01 Potential association of COVID-19 and ABO blood group: An Indian study Iti Garg, Swati Srivastava, Vikas Dogra, Mona Bargotya, Sonali Bhattar, Utkarsh Gupta, et al. (+8)
51 [GO] 2021―May―29 Identification of E484K and other novel SARS-COV-2 variants from the Kingdom of Bahrain Khalid Mubarak Bindayna, Abdel Halim Abdel Fattah Salem Deifalla, Hicham Ezzat Mohamed Mokbel
52 [GO] 2021―May―24 Phytochemicals present in Indian ginseng possess potential to inhibit SARS-CoV-2 virulence: A molecular docking and MD simulation study Prem Prakash Kushwaha, Atul Kumar Singh, Kumari Sunita Prajapati, Mohd Shuaib, Sanjay Gupta, Shashank Kumar
53 [GO] 2021―May―19 Detection of SARS-CoV-2 virus using an alternative molecular method and evaluation of biochemical, hematological, inflammatory, and oxidative stress in healthcare professionals Carla Marcelino Trassante, Victor dos Santos Barboza, Liziane dos Santos Rocha, Paulo Maximiliano Correa, Cristiane Luchese, Ethel Antunes Wilhelm, et al. (+5)
54 [GO] 2021―May―11 Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies Aadil Khursheed, Vikrant Jain, Ajaz Rasool, Manzoor A. Rather, Nisar Ahmad Malik, Aabid Hussain Shalla
55 [GO] 2021―May―04 Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis M. Nazmul Hoque, Salma Akter, Israt Dilruba Mishu, M. Rafiul Islam, M. Shaminur Rahman, Masuda Akhter, et al. (+6)
56 [GO] 2021―May―01 Analysis of pathogens and risk factors of secondary pulmonary infection in patients with COVID-19 Haicheng Tang, Zhangyan Zhao, Xiaolin Zhang, Lei Pan, Qingguo Wu, Mei Wang, et al. (+2)
57 [GO] 2021―Apr―29 Astemizole as a drug to inhibit the effect of SARS-COV-2 in vitro Xiangjun Wang, Jiayu Lu, Shuai Ge, Yajing Hou, Tian Hu, Yuexin Lv, et al. (+2)
58 [GO] 2021―Apr―28 Nanotechnology-based approaches for emerging and re-emerging viruses: Special emphasis on COVID-19 Muthupandian Saravanan, Ebrahim Mostafavi, Savariar Vincent, Hadush Negash, Rajapriya Andavar, Venkatesan Perumal, et al. (+4)
59 [GO] 2021―Mar―14 Mutations in SARS-CoV-2; Consequences in structure, function, and pathogenicity of the virus Behnaz Bakhshandeh, Zohreh Jahanafrooz, Ardeshir Abbasi, Matin Babaee Goli, Mahya Sadeghi, Mohammad Sadeq Mottaqi, Maryam Zamani
60 [GO] 2021―Mar―07 Contribution of STAT3 to the pathogenesis of COVID-19 Abdollah Jafarzadeh, Maryam Nemati, Sara Jafarzadeh
61 [GO] 2021―Feb―27 Latest updates on SARS-CoV-2 genomic characterization, drug, and vaccine development; a comprehensive bioinformatics review Masarra M. Sakr, Noha S. El Sayed, Ghadir S. El-Housseiny
62 [GO] 2021―Feb―19 The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong? Dounia Darif, Ikram Hammi, Ayyoub Kihel, Imane El Idrissi Saik, Fadila Guessous, Khadija Akarid
63 [GO] 2021―Feb―15 Variant analysis of SARS-CoV-2 genomes in the Middle East Khalid Mubarak Bindayna, Shane Crinion
64 [GO] 2021―Feb―05 Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients Mehdi Shahbazi, Zahra Moulana, Mahdi Sepidarkish, Mojgan Bagherzadeh, Maryam Rezanejad, Mohammad Mirzakhani, et al. (+2)
65 [GO] 2021―Jan―29 Inhibitory efficiency of potential drugs against SARS-CoV-2 by blocking human angiotensin converting enzyme-2: Virtual screening and molecular dynamics study Abdul Ashik Khan, Nabajyoti Baildya, Tanmoy Dutta, Narendra Nath Ghosh
66 [GO] 2021―Jan―11 Genetic characterization of a new NSP2-deletion porcine reproductive and Respiratory Syndrome Virus in China Chang-zhan Xie, Zheng Wang, Zhuo Ha, Ying Zhang, Yu-biao Xie, He Zhang, et al. (+8)
67 [GO] 2020―Dec―24 Applicability of MuLBSTA scoring system as diagnostic and prognostic role in early warning of severe COVID-19 Bei Ma, Jun Gong, Yu Yang, Xuan Yao, Xiaoqin Deng, Xi Chen
68 [GO] 2020―Dec―02 ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease HariOm Singh, Ranjana Choudhari, Vijay Nema, Abdul Arif Khan
69 [GO] 2020―Dec―02 The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options Shalki Choudhary, Kajal Sharma, Harpreet Singh, Om Silakari
70 [GO] 2020―Nov―23 Structural and functional insights into non-structural proteins of coronaviruses Mohammed A. Rohaim, Rania F. El Naggar, Emily Clayton, Muhammad Munir
71 [GO] 2020―Nov―16 An updated and comprehensive review of the antiviral potential of essential oils and their chemical constituents with special focus on their mechanism of action against various influenza and coronaviruses Abdul Rouf Wani, Kanchan Yadav, Aadil Khursheed, Manzoor Ahmad Rather
72 [GO] 2020―Nov―03 Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection Hossein Khorramdelazad, Mohammad Hossein Kazemi, Alireza Najafi, Maryam Keykhaee, Reza Zolfaghari Emameh, Reza Falak
73 [GO] 2020―Oct―20 Tunicamycin, an anticancer drug and inhibitor of N- linked glycosylation proteins is reliable to treat COVID-19 Ali Adel Dawood, Mahmood Abduljabar Altobje
74 [GO] 2020―Oct―19 The emergence of a novel recombinant porcine reproductive and respiratory syndrome virus with an amino acid insertion in GP5 protein Zhongbao Song, Qiaoya Zhang, Ye Chen, Haiyang Shen, Guang Yang, Ping Jiang, et al. (+2)
75 [GO] 2020―Oct―14 Development and immunogenic potentials of chitosan-saponin encapsulated DNA vaccine against avian infectious bronchitis coronavirus Faruku Bande, Siti Suri Arshad, Mohd Hair Bejo, Abdul Rahman Omar, Hassan Moeini, Saed Khadkodae, et al. (+4)
76 [GO] 2020―Oct―05 Study presence of COVID-19 (SARS-CoV-2) in the sweat of patients infected with Covid-19 Hadis Fathizadeh, Sepehr Taghizadeh, Rohollah Safari, Saeid Shabestari Khiabani, Bayaz Babak, Fatemeh Hamzavi, et al. (+6)
77 [GO] 2020―Oct―01 Novel cyclohexanone compound as a potential ligand against SARS-CoV-2 main-protease Soumya Basu, Balaji Veeraraghavan, Sudha Ramaiah, Anand Anbarasu
78 [GO] 2020―Sep―25 Genetic analysis of a porcine reproductive and respiratory syndrome virus 1 strain in China with new patterns of amino acid deletions in nsp2, GP3 and GP4 Qiaoya Zhang, Zhongbao Song, Ying Yu, Juan Huang, Ping Jiang, Hu Shan
79 [GO] 2020―Sep―17 Use of Nasoil® via intranasal to control the harmful effects of Covid-19 Carlos Eduardo Cuevas-Barragan, Marco Tulio Buenrostro-Nava, Gabriela Monserrat Palos- Gómez, Elisa Alejandra Ramirez-Padilla, Blanca Isabel Mendoza-Macias, Raymundo Rene Rivas-Caceres
80 [GO] 2020―Sep―09 Immune response in COVID-19: What do we currently know? Daniela Silva de Oliveira, Nayara I. Medeiros, Juliana A.S. Gomes
81 [GO] 2020―Aug―21 Identification B and T-Cell epitopes and functional exposed amino acids of S protein as a potential vaccine candidate against SARS-CoV-2/COVID-19 Maryam Tohidinia, Fatemeh Sefid
82 [GO] 2020―Aug―18 The immunomodulatory effects of probiotics on respiratory viral infections: A hint for COVID-19 treatment? Mehran Mahooti, Seyed Mohammad Miri, Elahe Abdolalipour, Amir Ghaemi
83 [GO] 2020―Jul―20 Corrigendum to “Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2” [Microbial Pathog. 145 (2020) 104236] Parismita Kalita, Aditya K. Padhi, Kam Y.J. Zhang, Timir Tripathi
84 [GO] 2020―Jul―15 Clinical characteristics, laboratory findings, radiographic signs and outcomes of 61,742 patients with confirmed COVID-19 infection: A systematic review and meta-analysis Ali Pormohammad, Saied Ghorbani, Behzad Baradaran, Alireza Khatami, Raymond J. Turner, Mohammad Ali Mansournia, et al. (+3)
85 [GO] 2020―Jul―11 Identification of enterobacteria in viscera of pigs afflicted with porcine reproductive and respiratory syndrome and other viral co-infections Ge Zhao, Lujie Zhang, Charles Li, Jianmei Zhao, Na Liu, Yuehua Li, et al. (+2)
86 [GO] 2020―Jun―30 Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease Emanuelle Machado Marinho, João Batista de Andrade Neto, Jacilene Silva, Cecília Rocha da Silva, Bruno Coelho Cavalcanti, Emmanuel Silva Marinho, Hélio Vitoriano Nobre Júnior
87 [GO] 2020―May―28 A review of South Indian medicinal plant has the ability to combat against deadly viruses along with COVID-19? Mani Divya, Sekar Vijayakumar, Jingdi Chen, Baskaralingam Vaseeharan, Esteban F. Durán-Lara
88 [GO] 2020―May―05 Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19) Ehsaneh Khodadadi, Parham Maroufi, Ehsan Khodadadi, Isabella Esposito, Khudaverdi Ganbarov, Silvano Espsoito, et al. (+3)
89 [GO] 2020―May―04 Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2 Parismita Kalita, Aditya K. Padhi, Kam Y.J. Zhang, Timir Tripathi
90 [GO] 2020―Apr―25 In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect Julien Andreani, Marion Le Bideau, Isabelle Duflot, Priscilla Jardot, Clara Rolland, Manon Boxberger, et al. (+5)
91 [GO] 2020―Apr―18 Etiology and genetic evolution of canine coronavirus circulating in five provinces of China, during 2018-2019 Hai-Jian He, Wenyan Zhang, Jiawei Liang, Meng Lu, Ruyi Wang, Gairu Li, et al. (+4)
92 [GO] 2020―Mar―31 Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids Gerard Kian-Meng Goh, A. Keith Dunker, James A. Foster, Vladimir N. Uversky
93 [GO] 2020―Mar―20 Genetic signatures of the immune-escaping type 2 porcine reproductive and respiratory syndrome virus in farms with a robust vaccination program Wimontiane Saenglub, Tippawan Jantafong, Chatthapon Mungkundar, Narin Romlamduan, Sunan Pinitkiatisakul, Porntippa Lekcharoensuk
94 [GO] 2020―Feb―29 Porcine reproductive and respiratory syndrome virus up-regulates sialoadhesin via IFN-STAT signaling to facilitate its infection Yingqi Liu, Rui Li, Yuyang Zhang, Songlin Qiao, Xin-xin Chen, Gaiping Zhang
95 [GO] 2019―Dec―18 Characterization of porcine reproductive and respiratory syndrome virus (ORF5 RFLP 1-7-4 viruses) in northern China Changzhan Xie, Zhuo Ha, Fulong Nan, Ying Zhang, Han Zhang, Jinfeng Li, et al. (+7)
 [1] 

95 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.023 sec